Generics
topic on 4 shows · 6 statements across 4 episodes
Cheeky Pint 
WTF is with Nikhil Kamath 
Invest Like the Best 
the a16z Podcast
6 statements about Generics, every show
Prasad: Generics and drug innovation are fundamentally different business models
“Innovation and generics They are not a continuum. People like to say, we're moving up the value chain, we're going to innovation. It's a very different business.”
Sankar: Reshoring generic drug manufacturing to the US will never be viable
“If you try to do that for generics, the business case will never work. It's too hard. It's too much of a subsidy.”
Ricks: Drugs lose 97% of their pricing when patents expire
“Typically a generic event, you'll lose 97% of your pricing the day your patent expires.”
Ricks: Virtually no generic pharmaceuticals are manufactured in the US
“There are no generics manufactured in the U.S. Really.”
Ricks: Healthcare systems should pay a premium for generic drug resilience
“And we probably should pay a little bit more for generics. You sometimes read about injectable generics in particular that run short. That's a more complicated manufacturing process. So if you do it cheaply, you run into more problems. We probably should pay a…”